Skip to main content

Advertisement

Log in

Phosphorylation of c-Jun N-terminal Kinases (JNKs) is involved in the preventive effect of xanthorrhizol on cisplatin-induced hepatotoxicity

  • Organ Toxicity and Mechanisms
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Cisplatin is a potent anti-cancer chemotherapeutic agent but has the undesirable side effect of hepatotoxicity at high doses. In a previous study, abrogation of cisplatin-induced hepatotoxicity by pretreatment with xanthorrhizol was observed in mice, but the mechanism has not yet been studied. We therefore investigated whether the protective effect of xanthorrhizol on cisplatin-induced hepatotoxicity is associated with the mitogen-activated protein (MAP) kinase-signaling pathway. Cisplatin caused phosphorylation of both c-Jun N-terminal kinases 1/2 (JNK1/2) and the extracellular signal-regulated kinase 1/2 (ERK1/2), but not that of p38. However, cisplatin-induced phosphorylation of JNKs, especially JNK1, was highly attenuated by pretreatment with xanthorrhizol in a dose-dependent manner. This study suggested that the phosphorylation of JNKs could be involved in the protective effect of xanthorrhizol on cisplatin-induced hepatotoxicity and it also affects gene transcription by regulating the expression of transcription factor subunits such as c-fos and p50 in part. In addition, considering that the expression of both cytochrome c and caspase-9 were not changed in this model, its mechanism might be independent of mitochondria-related apoptosis. This is the first report giving evidence that the physiological function of xanthorrhizol is linked to regulation of the phosphorylation of JNK(s).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AP-1:

Activator protein 1

COX-2:

Cyclooxygenase-2

ERK:

Extracellular signal-regulated kinase

JNK:

c-Jun N-terminal kinase

MAP:

Mitogen-activated protein

iNOS:

Inducible nitric oxide synthase

NF-κB:

Nuclear factor-kappaB.

References

  • Cavalli F, Tschopp L, Sonntag RW, Zimmerman A (1978) A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment. Cancer Treat Rep 62:2125–2126

    CAS  PubMed  Google Scholar 

  • Cersosimo RJ (1993) Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharm 27:438–441

    CAS  Google Scholar 

  • Cui W, Yazlovitskaya EM, Mayo MS, Pelling JC, Persons DL (2000) Cisplatin-induced response of c-Jun N-terminal Kinase1 and Extracellular signal-regulated protein kinase 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. Mol Carcinog 29:219–228

    Article  CAS  PubMed  Google Scholar 

  • Donatus IA, Sardjoko L, Vermeulen NP (1990) Cytotoxic and cytoprotective activities of curcumin. Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes. Biochem Pharmacol 39:1869–1875

    Article  CAS  PubMed  Google Scholar 

  • Kim SH, Hong KO, Chung WY, Hwang JK, Park KK (2004) Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. Toxicol Appl Pharmacol 196:346–355

    Article  CAS  PubMed  Google Scholar 

  • Kiso Y, Suzuki Y, Watanabe N, Oshima Y, Hikino H (1983) Antihepatotoxic principles of Curcuma longa rhizomes. Planta Med 49:185–187

    CAS  PubMed  Google Scholar 

  • Kobayashi K, Tsukamoto I (2001) Prolonged Jun N-terminal kinase (JNK) activation and the upregulation of p53 and p21(WAF1/CIP1) preceded apoptosis in hepatocytes after partial hepatectomy and cisplatin. Biochim Biophys Acta 1537:79–88

    CAS  PubMed  Google Scholar 

  • Lin SC, Lin CC, Lin YH, Supriyatna S, Teng CW (1995). Protective and therapeutic effects of Curcuma xanthorrhizol on hepatotoxin-induced liver damage. Am J Chin Med 23:243–254

    CAS  PubMed  Google Scholar 

  • Liu J, Liu Y, Habeebu SS, Klaassen CD (1998) Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol Appl Pharmacol 149:24–31

    Article  CAS  PubMed  Google Scholar 

  • Loehrer PJ, Einhorn LH (1984) Drugs five years later. Cisplatin. Ann Intern Med 100:704–713

    CAS  PubMed  Google Scholar 

  • Madias NE, Harrington JT (1978) Platinum nephrotoxicity. Am J Med 65:307–314

    Article  CAS  PubMed  Google Scholar 

  • Minden A, Karin M (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333:F85–F104

    CAS  PubMed  Google Scholar 

  • Park EJ, Jeon CH, Ko G, Kim J, Sohn DH (2000) Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol 52:437–440

    Article  CAS  PubMed  Google Scholar 

  • Persons DL, Yazlovitskaya EM, Cui W, Pelling JC (1999) Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res 5:1007–1014

    CAS  PubMed  Google Scholar 

  • Pollera CF, Meglio F, Nardi M, Vitelli G, Morolla P (1987) Cisplatin-induced hepatic toxicity. J Clin Oncol 5:318–319

    CAS  Google Scholar 

  • Potapova O, Haghighi A, Bost F, Liu C, Birrer MJ, Gjerset R, Mercola D (1997) The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J Biol Chem 272:14041–14044

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Perez I, Murguia JR, Perona R (1998) Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16:533–540

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Perez I, Perona R (1999) Lack of c-Jun activity increases survival to cisplatin. FEBS Lett 453:151–158

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Perez I, Martinez-Gomariz M, Williams D, Keyse SM, Perona R (2000) CL100/MKP1 modulates JNK activation, and apoptosis in response to cisplatin. Oncogene 19:5142–5152

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Perez I, Benitah SA, Martinez-Gomariz M, Lacal JC, Perona R (2002) Cell stress and MEKK1-mediated c-Jun activation modulate NFκB activity and cell viability. Mol Biol Cell 13:2933–2945

    Article  CAS  PubMed  Google Scholar 

  • Smeal T, Angel P, Meek J, Karin M (1989) Different requirements for formation of Jun: Jun and Jun: Fos complexes. Genes Dev 3:2091–2100

    CAS  PubMed  Google Scholar 

  • Song L, Ma X, Li Y, Cui X, Wang X (2003) Effects of nuclear translocation of tissue transglutaminase and the release of cytochrome C on hepatocyte apoptosis. Chin Med J 116:742–746

    CAS  PubMed  Google Scholar 

  • Treisman R (1996) Regulation of transcription by MAP kinase cascades. Cur Opin Cell Biol 8:205–215

    Article  CAS  Google Scholar 

  • Wang X, Martindale JL, Holbrook NJ (2000) Requirement of ERK activation in cisplatin-induced apoptosis. J Biol Chem 275:39435–39443

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

PKK work was supported by the Research Fund from Yonsei University College of Dentistry Research Fund of 1999.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seong Hwan Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hong, K.O., Hwang, J.K., Park, KK. et al. Phosphorylation of c-Jun N-terminal Kinases (JNKs) is involved in the preventive effect of xanthorrhizol on cisplatin-induced hepatotoxicity. Arch Toxicol 79, 231–236 (2005). https://doi.org/10.1007/s00204-004-0623-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-004-0623-7

Keywords

Navigation